The company was established in February 2023 and is located in Tai'an Zhongzhi Life and Health Industrial Park, High tech Zone, Tai'an City. Its registered capital is 20 million US dollars and it covers an area of 80 acres. The company is built according to Chinese GMP standards and meets EU and US FDA certification standards. It has built 10 production workshops, analysis centers, comprehensive buildings, and related supporting units, with a total construction area of 69000 square meters. The company focuses on the research and development, production, and sales of high-end formulations such as long-acting formulations, sustained-release formulations, and targeted nano formulations, with research and development centers in Beijing and Guangzhou. At present, we have participated in the research and development of more than 20 listed products and more than 10 clinical products, involving full dosage forms of drugs such as cardiovascular and cerebrovascular nervous suppression, immune suppression, and tumor targeting.